Characterization of the human cysteinyl leukotriene CysLT1 receptor
Kevin R. Lynch(Duke University), Jilly F. Evans(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhizhen Zeng(Merck & Co., Inc., Rahway, NJ, USA (United States)), David L. Williams(East Tennessee State University), Christopher P. Austin(Unknown), Elizabeth M. Hosfield(University of Virginia), David J. Figueroa(United States Military Academy), Dong‐Soon Im(Kyung Hee University), Shelley B. Hooks(University of Georgia), Brett Connolly(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicole Sawyer(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kathleen M. Metters(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nathalie Coulombe(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mark Abramovitz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qingyun Liu(Chinese Academy of Sciences), Rino Stocco(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gary P. O’Neill(La Jolla Alcohol Research), C. Thomas Caskey(Baylor College of Medicine), Chang Bai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Anthony W. Ford‐Hutchinson(United States Military Academy), Anne Châteauneuf(Merck & Co., Inc., Rahway, NJ, USA (United States)), Gillian Greig(University of Toronto), Stacia Kargman(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 970